Literature DB >> 23179572

Assessment of bone mineral density and radiographic texture analysis at the tibial subchondral bone.

E Lespessailles1, R Jennane.   

Abstract

Microstructural changes of subchondral bone constitute one of the figures characterising osteoarthritis on a structural level. Subchondral bone mineral density may reflect the complex relationship between bone and cartilage submitted to movement and loading. In this review, the authors discussed the interest of tibial subchondral bone mineral density assessment in the perspective of its diagnostic, etiopathogenic and prognostic value in osteoarthritis. In addition, the sources of variability linked to the measurement of tibial subchondral bone mineral density are precised. Trabecular bone structure characterisation by radiographic texture analyses may also represent a new promising tool to evaluate the microarchitectural changes that occur with initiation and progression of osteoarthritis. In this paper, the authors also highlighted the interest of different radiographic texture analyses and their clinical relevance in the field of osteoarthritis.

Entities:  

Mesh:

Year:  2012        PMID: 23179572     DOI: 10.1007/s00198-012-2167-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  2 in total

1.  Prediction of knee osteoarthritis progression using radiological descriptors obtained from bone texture analysis and Siamese neural networks: data from OAI and MOST cohorts.

Authors:  Ahmad Almhdie-Imjabbar; Khac-Lan Nguyen; Hechmi Toumi; Rachid Jennane; Eric Lespessailles
Journal:  Arthritis Res Ther       Date:  2022-03-08       Impact factor: 5.156

Review 2.  Trabecular bone texture analysis of conventional radiographs in the assessment of knee osteoarthritis: review and viewpoint.

Authors:  Ahmad Almhdie-Imjabbar; Pawel Podsiadlo; Richard Ljuhar; Rachid Jennane; Khac-Lan Nguyen; Hechmi Toumi; Simo Saarakkala; Eric Lespessailles
Journal:  Arthritis Res Ther       Date:  2021-08-06       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.